Recruiting Atrial Fibrillation Studies in Nashville
About Atrial Fibrillation Clinical Trials in Nashville
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 4 atrial fibrillation clinical trials recruiting participants in Nashville, TX. These studies are seeking a combined 390 participants. Research is being sponsored by Vanderbilt University Medical Center, Regeneron Pharmaceuticals, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Nashville — FAQ
Are there atrial fibrillation clinical trials in Nashville?
Yes, there are 4 atrial fibrillation clinical trials currently recruiting in Nashville, TX. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Nashville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.
Are clinical trials in Nashville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 4 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated July 13, 2026 from ClinicalTrials.gov